Detalhe da pesquisa
1.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology
; 78(2): 397-415, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386786
2.
Prevalence of elevated liver enzymes and comorbidities in children and adolescents with overweight and obesity.
Acta Paediatr
; 110(3): 985-992, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649794
3.
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 18(11): 2544-2553.e6, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32621971
4.
Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras.
J Clin Microbiol
; 57(7)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043467
5.
[ELABORATION AND TREATMENT DECISION IN INCIDENTAL SPLANCHNIC VEIN THROMBOSIS].
Harefuah
; 158(3): 176-179, 2019 Mar.
Artigo
em Hebraico
| MEDLINE | ID: mdl-30916505
6.
Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.
J Hepatol
; 67(4): 680-686, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619439
7.
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.
Clin Infect Dis
; 62(1): 32-6, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26371152
8.
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.
Lancet
; 386(10003): 1537-45, 2015 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26456905
9.
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial.
Lancet
; 385(9973): 1087-97, 2015 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25467560
10.
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent.
J Hepatol
; 63(3): 564-72, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25895428
11.
Secondary sclerosing cholangitis following major burn.
Ann Hepatol
; 14(5): 695-701, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26256898
12.
Evaluation and treatment of esophageal varices in the cirrhotic patient.
Isr Med Assoc J
; 15(2): 109-15, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23516775
13.
[Treatment of hepatitis C virus--2012: a real breakthrough].
Harefuah
; 151(12): 699-704, 719, 2012 Dec.
Artigo
em Hebraico
| MEDLINE | ID: mdl-23330264
14.
[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].
Harefuah
; 151(12): 709-14, 719, 2012 Dec.
Artigo
em Hebraico
| MEDLINE | ID: mdl-23330266
15.
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.
Nat Med
; 28(7): 1432-1438, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725922
16.
Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine.
Liver Int
; 31(5): 667-75, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21040410
17.
Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data.
Liver Int
; 31 Suppl 2: 4-17, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21651700
18.
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Liver Int
; 31 Suppl 2: 30-60, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21651702
19.
Hand-assisted laparoscopic surgery for liver tumors.
Isr Med Assoc J
; 12(7): 424-7, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20862824
20.
High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life data.
Antivir Ther
; 24(3): 221-228, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880684